Results 171 to 180 of about 3,230,793 (311)

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

open access: yesMolecular Oncology, EarlyView.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh   +12 more
wiley   +1 more source

An instrument to measure the solar spectrum from 170 to 3200 nm on board Spacelab [PDF]

open access: yes
This instrument, at the present time in development, will fly on board Spacelab I in May 1983. Other flights are foreseen during the following missions. The instrument is composed of three double monochromators covering the range 170 to 3200 nm.
Labs, D.   +4 more
core   +1 more source

Systematic Nutritional Clinical Assessment (SyNCA): Instrument Development, Delphi Protocol for Content, and Semantic Validation. [PDF]

open access: yesJ Hum Nutr Diet
Jesus RP   +11 more
europepmc   +1 more source

Childbirth Readiness Scale (CRS): instrument development and psychometric properties. [PDF]

open access: yesBMC Pregnancy Childbirth, 2022
Mengmei Y   +6 more
europepmc   +1 more source

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Develop real-time dosimetry concepts and instrumentation for long term missions [PDF]

open access: yes
The development of a rugged portable instrument to evaluate dose and dose equivalent is described. A tissue-equivalent proportional counter simulating a 2 micrometer spherical tissue volume was operated satisfactorily for over a year.
Braby, L. A.
core   +2 more sources

Digital maturity index instrument development for primary health care in Indonesia: a sequential exploratory mixed-methods approach. [PDF]

open access: yesBMC Health Serv Res
Anwar SJ   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy